Radius Health PE Ratio 2010-2020 | RDUS

Current and historical p/e ratio for Radius Health (RDUS) from 2010 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Radius Health PE ratio as of August 11, 2020 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Radius Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-08-11 12.36 0.00
2020-03-31 13.00 $-2.77 0.00
2019-12-31 20.16 $-2.90 0.00
2019-09-30 25.75 $-3.26 0.00
2019-06-30 24.36 $-3.70 0.00
2019-03-31 19.94 $-4.45 0.00
2018-12-31 16.49 $-4.88 0.00
2018-09-30 17.80 $-5.57 0.00
2018-06-30 29.47 $-5.79 0.00
2018-03-31 35.94 $-5.85 0.00
2017-12-31 31.77 $-5.80 0.00
2017-09-30 38.55 $-5.43 0.00
2017-06-30 45.23 $-5.19 0.00
2017-03-31 38.65 $-4.62 0.00
2016-12-31 38.03 $-4.24 0.00
2016-09-30 54.09 $-3.79 0.00
2016-06-30 36.75 $-3.40 0.00
2016-03-31 31.44 $-3.00 0.00
2015-12-31 61.54 $-2.53 0.00
2015-09-30 69.31 $-2.31 0.00
2015-06-30 67.70 $-2.22 0.00
2015-03-31 41.16 $-3.83 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.585B $0.173B
Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius Health Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.116B 42.73
Takeda Pharmaceutical (TAK) Japan $57.348B 9.99
Astellas Pharma (ALPMY) Japan $29.096B 14.74
Eisai (ESALY) Japan $26.083B 22.04
UCB SA (UCBJF) Belgium $24.702B 0.00
Merck (MKGAF) Germany $17.448B 22.88
Catalent (CTLT) United States $13.567B 52.45
Grifols, S.A (GRFS) Spain $11.998B 14.66
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.497B 40.63
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
Ionis Pharmaceuticals (IONS) United States $7.558B 47.88
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $7.007B 11.59
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.927B 11.39
Arrowhead Pharmaceuticals (ARWR) United States $4.130B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
FibroGen (FGEN) United States $4.080B 0.00
Hypermarcas (HYPMY) Brazil $3.873B 14.25
Nektar Therapeutics (NKTR) United States $3.820B 0.00
ChemoCentryx (CCXI) United States $3.447B 0.00
PTC Therapeutics (PTCT) United States $3.252B 0.00
Sage Therapeutics (SAGE) United States $2.768B 0.00
Pacira BioSciences (PCRX) United States $2.607B 68.53
Taro Pharmaceutical Industries (TARO) Israel $2.434B 11.78
Cronos Group (CRON) Canada $2.029B 0.00
Xencor (XNCR) United States $1.815B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.810B 0.00
USANA Health Sciences (USNA) United States $1.704B 16.05
Revolution Medicines (RVMD) United States $1.682B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.622B 11.31
Indivior (INVVY) United States $1.605B 19.90
Corcept Therapeutics (CORT) United States $1.597B 14.70
Heron Therapeutics (HRTX) United States $1.408B 0.00
Akebia Therapeutics (AKBA) United States $1.390B 0.00
Zogenix (ZGNX) United States $1.362B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.309B 12.49
CLINIGEN GP (CLIGF) United Kingdom $1.142B 0.00
Translate Bio (TBIO) United States $1.126B 0.00
Karyopharm Therapeutics (KPTI) United States $1.117B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.107B 0.00
VAXART, INC (VXRT) United States $1.026B 0.00
Esperion Therapeutics (ESPR) United States $1.022B 0.00
Tilray (TLRY) Canada $0.995B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.961B 600.25
Altimmune (ALT) United States $0.835B 0.00
Endo (ENDP) Ireland $0.765B 1.13
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.729B 0.00
ImmunoGen (IMGN) United States $0.703B 0.00
Trillium Therapeutics (TRIL) Canada $0.685B 0.00
Collegium Pharmaceutical (COLL) United States $0.652B 0.00
Flexion Therapeutics (FLXN) United States $0.617B 0.00
Aerie Pharmaceuticals (AERI) United States $0.600B 0.00
Molecular Templates (MTEM) United States $0.597B 0.00
Siga Technologies (SIGA) United States $0.592B 63.17
Corbus Pharmaceuticals Holdings (CRBP) United States $0.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.560B 0.00
Ocular Therapeutix (OCUL) United States $0.533B 0.00
Ardelyx (ARDX) United States $0.507B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.499B 24.87
Innate Pharma SA (IPHYF) France $0.489B 0.00
DURECT (DRRX) United States $0.469B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.458B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.441B 10.94
Rigel Pharmaceuticals (RIGL) United States $0.439B 0.00
TherapeuticsMD (TXMD) United States $0.428B 0.00
Organogenesis Holdings (ORGO) United States $0.409B 0.00
Heat Biologics (HTBX) United States $0.360B 0.00
Redhill Biopharma (RDHL) Israel $0.345B 0.00
Harpoon Therapeutics (HARP) United States $0.336B 0.00
Calithera Biosciences (CALA) United States $0.332B 0.00
OptiNose (OPTN) United States $0.317B 0.00
IMV INC (IMV) Canada $0.316B 0.00
Concert Pharmaceuticals (CNCE) United States $0.310B 0.00
Rafael Holdings (RFL) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.294B 0.00
PROFOUND MEDICL (PROF) Canada $0.288B 0.00
MEI Pharma (MEIP) United States $0.288B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Lannett Co Inc (LCI) United States $0.255B 5.58
Aquestive Therapeutics (AQST) United States $0.234B 0.00
CASI Pharmaceuticals (CASI) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.212B 20.92
KalVista Pharmaceuticals (KALV) United States $0.210B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Nivalis Therapeutics (ALPN) United States $0.193B 0.00
Onconova Therapeutics (ONTX) United States $0.189B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.172B 8.13
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.135B 0.00
Xeris Pharmaceuticals (XERS) United States $0.132B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.107B 0.00
Lipocine (LPCN) United States $0.103B 0.00
Hemispherx BioPharma (AIM) United States $0.100B 0.00
Otonomy (OTIC) United States $0.100B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Biomerica (BMRA) United States $0.099B 0.00
MediWound (MDWD) Israel $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.099B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
CTI BioPharma (CTIC) United States $0.096B 0.00
Aclaris Therapeutics (ACRS) United States $0.093B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
ElectroCore (ECOR) United States $0.084B 0.00
Addex Therapeutics (ADXN) Switzerland $0.080B 0.00
Recro Pharma (REPH) United States $0.079B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
CV Sciences (CVSI) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
PolarityTE (PTE) United States $0.060B 0.00
GTx (ONCT) United States $0.059B 0.00
Sundial Growers (SNDL) Canada $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Novan (NOVN) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.82
AgeX Therapeutics (AGE) United States $0.049B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
IsoRay (ISR) United States $0.045B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.043B 8.19
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Vical (BBI) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 36.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Midatech Pharma (MTP) United Kingdom $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00